Clear Search
·
14 MIN READ

AMA president outlines efforts to attack dysfunction in health care

Dr. McAneny also issues urgent calls for physician leadership to help reduce gun violence in America, end harassment in medicine

Press Releases
Two delegates consulting at 2018 AMA Interim Meeting
·
2 MIN READ

AMA: Fix hospital eligibility criteria for drug-discount program

Outpatient charity care should determine 340B program eligibility as part of a revised formula for the federal program, physicians say.

Public Health
Barbara L. McAneny, MD at 2018 AMA Interim Meeting
·
5 MIN READ

AMA president: Create system that values health over money, power

AMA President Barbara L. McAneny, MD, says the AMA is fighting the forces that make the U.S. health system so dysfunctional.

Interim Meeting
·
3 MIN READ

AMA policy on in-person importation of prescription drugs from Canada

Physicians at the Interim Meeting of the AMA adopted policy supporting in-person importation of prescription drugs from licensed Canadian pharmacies.

Press Releases
Presenting at a panel
·
2 MIN READ

AMA backs in-person import of Canadian Rx if safety is assured

Allowing the practice offers patients an option to lower patient out-of-pocket spending on prescription drugs, which addresses a barrier to medication adherence: unaffordability.

Public Health
·
8 MIN READ

Nov. 1, 2018: National Advocacy Update

Trump administration on drug prices, FTC and insulin prices and more in the latest from AMA's national advocacy news.

Advocacy Update
·
1 MIN READ

AMA statement on president’s plan for prescription drugs

Physicians share their patients’ concerns with the cost of prescription drugs. We appreciate the Trump Administration addressing this important issue.

Press Releases
·
11 MIN READ

Oct. 18, 2018: National Advocacy Update

Drug prices in TV ads, Surgeon General's opioid report and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 MIN READ

AMA on proposal to increase transparency in drug ads

While AMA is opposed to consumer advertising of prescription drugs, since the practice is allowed, ads should come with at least a small dose of transparency.

Press Releases